471 NAC 16-002

471 NAC 16-002. DRUG UTILIZATION REVIEW

Last amended: 2021Year: 2026Length: 128 wordsOfficial source

Cite as Neb. Admin. Code tit. 471, ch. 16, § 002

002. DRUG UTILIZATION REVIEW. As a condition of participation, the provider is required to: (A) Provide prospective drug utilization review before dispensing each prescription. This includes screening for: (i) Therapeutic duplication; (ii) Drug disease contraindications; (iii) Drug interactions; (iv) Incorrect dosage or duration; (v) Drug allergies; and (vi) Clinical abuse and misuse; (B) Provide patient counseling on all matters which, in the provider's professional judgment, are deemed significant, including: (i) Name and description of the medication; (ii) Route, dosage form, duration of therapy; (iii) Directions for use; (iv) Adverse reactions, contraindications; (v) Storage; and (vi) Refill information; and (C) Maintain adequate patient profiles which may include: (i) Name, address, phone number, date of birth, and gender; (ii) Individual history; (iii) Comprehensive listing of medications; and (iv) Relevant comments.
471 NAC 16-002: 471 NAC 16-002. DRUG UTILIZATION REVIEW | Justis AI